A leading drug candidate for low sexual desire in women hasn't gotten approved for use in the United States, but the company backing it isn't giving up. Low sexual desire in women isn't necessarily a problem in menopause or later. That's the technical term for when women have a distressing lack or absence of sexual desire or fantasy. Where's the sex drive drug for women? Sprouting a drug Flibanserin was initially developed by pharmaceutical giant Boehringer Ingelheim, but the company ditched it in 2010 after the FDA declined to approve their new drug application, asking for more research, said Dr. Irwin Goldstein, director of sexual medicine at Alvarado Hospital in San Diego, California, who collaborated on clinical trials for flibanserin. Sex is doctor's life's work A 2013 study in the Journal of Sexual Medicine showed that women taking the drug reported an average increase of 2.5 satisfying sexual events in four weeks, compared to an increase of 1.5 among women using a placebo.